| Code | Description | Claims | Beneficiaries | Total Paid |
| 67028 |
Intravitreal injection of a pharmacologic agent |
11,536 |
8,634 |
$545K |
| J0178 |
Injection, aflibercept, 1 mg |
500 |
275 |
$184K |
| 92134 |
|
16,491 |
12,828 |
$115K |
| J2778 |
Injection, ranibizumab, 0.1 mg |
370 |
208 |
$84K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
1,131 |
916 |
$30K |
| 92250 |
|
851 |
665 |
$13K |
| J3590 |
Unclassified biologics |
301 |
203 |
$5K |
| 92235 |
|
129 |
101 |
$4K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
146 |
117 |
$3K |
| J9035 |
Injection, bevacizumab, 10 mg |
75 |
38 |
$3K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
17 |
13 |
$116.62 |